The severity of skin reactions to the treatment of actinic keratosis with 5-fluorouracil cream 4% was associated with a higher lesion clearance rate.

The medication names of the current FDA-approved topical agents for the treatment of AK including Carac® (Sanofi-Aventis, NJ, USA), Efudex® (Valeant, CA, USA) and Fluoroplex® (Allergan ...

Patients with BRAF V600E-mutated metastatic colorectal cancer experienced improved responses when treated with Braftovi plus Erbitux and mFOLFOX6.

Pfizer’s metastatic colorectal cancer (mCRC) combination therapy has met one of the primary endpoints of improving ...

Pfizer Inc. (NYSE: PFE) today announced positive topline results from the progression-free survival (PFS) analysis of the ...

In the ALEXANDRA/IMpassion030 trial, Tecentriq (atezolizumab) added to postoperative chemotherapy was not found to improve ...

5-Fluorouracil and other p53-activating cytotoxic ... that immune reactions might contribute to the efficacy of treatment. For example, since 1976, the National Cancer Institute, USA, has used ...

A study reveals a novel adhesive patch prototype using AgNP-Cx+ for enhanced anti-tumor activity against melanoma, showcasing ...

Three trials presented at ASCO GI 2025 will change practice and improve the treatment of colorectal cancer, according to experts.

We aimed to assess the real-world impact of adjuvant oxaliplatin treatment on the survival of these patients ... we excluded these patients by censoring those who received biweekly fluorouracil-based ...

Pfizer's Braftovi combination showed significant survival benefits in a Phase 3 study for BRAF V600E-mutant metastatic ...

7, 2024 — Doctors have long believed the cancer drug 5-fluorouracil works by damaging the building blocks of DNA, but researchers have now found that in certain cancers, it kills cells by ...